Transcription Factor DLX5 As a New Target for Promising Antitumor Agents

Abstract

The crystal structure of the human transcription factor DLX5 has been used for the screening of a library consisting of 10(6 )compounds by the molecular docking technique.In vitro testsof the 14 top-rated ligands showed that compound Q12 displays the best ability to inhibit the proliferation ofDlx5 positive mouse lymphoma cells, which correlates with the… (More)

Topics

5 Figures and Tables

Slides referencing similar topics